HOT NEWS
COAGADEX® Earns Orphan Drug Designation for Rare Bleeding Disorder
Kedrion Biopharma has announced a major step forward in rare disease treatment: its plasma-derived therapy, COAGADEX® (Coagulation Factor X, Human), has received Orphan Drug...
EMA Issues Positive Opinion on Mirdametinib for NF1-Associated Plexiform Neurofibromas
On 22 May 2025, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended granting a conditional marketing authorisation for mirdametinib...
Kedrion Biopharma Advances COAGADEX for Rare Bleeding Disorder with New FDA Designation and Clinical Trial
Kedrion Biopharma has received Orphan Drug Designation from the U.S. FDA for COAGADEX®, a plasma-derived human coagulation factor concentrate, targeting Acquired Factor X...
Long-Term Benefits of TIBSOVO® in IDH1-Mutated AML: A Summary of the Phase 3 AGILE Trial Results
Servier recently published updated long-term data from the Phase 3 AGILE trial in Blood Advances, confirming the sustained survival benefit of TIBSOVO® (ivosidenib) combined with...
European Commission Approves DARZALEX Faspro for High-Risk Smouldering Multiple Myeloma
On July 23, 2025, the European Commission approved DARZALEX Faspro® (daratumumab), co-formulated with Halozyme's ENHANZE® technology, as monotherapy for adult patients with...
Don't hesitate to contact us ,please click inquiry.
We will be to keep your information strictly confidential
Leave Your Message
TOP 6 USER FOLLOW
TOP
1
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements.
TOP
2
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in Parkinson's disease.
TOP
3
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and older.
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion.
DatopotamabDeruxtecan-dlnk(Datroway)
Treatment of unresectable or metastatic HR-positive, HER2-negative breast cancer in adults who have received prior endocrine therapy and chemotherapy.
Vadadustat(Vafseo)
Treatment of anemia in adults with chronic kidney disease (CKD) who have been on dialysis for at least three months.
Company Introduction
Seagull Pharmacy offers a diverse range of medications, including both prescription
and over-the-counter drugs.
The platform prioritizes medication quality and provides 24/7 services.
Whether it's consultation on medication purchases or post-sale support, Seagull Pharmacy strives to deliver
meticulous care in every detail,
consistently placing customers' needs at the forefront.
Click here to contact us
LATEST ARTICLES
- Dosage, Administration, Precautions, and Healthy Lifestyle Recommendations for Eltrombopag (Revolade)Eltrombopag is a prescription medication. Proper use directly impacts its efficacy and safety.
502
2026-04-10 11:14:40 - A Complete Analysis of the Price, Medical Insurance Coverage and Efficacy of Eltrombopag (Revolade)Eltrombopag is a targeted drug used to increase platelet count. Patients are most concerned about its price, medical insurance reimbursement, and actual therapeutic effects.501
2026-04-10 09:39:51
- Ibrutinib (Imbruvica): Side Effects, Management Strategies and Storage GuidelinesIbrutinib (Imbruvica) is a Bruton's tyrosine kinase (BTK) inhibitor indicated for the treatment of various B-cell malignancies and chronic graft-versus-host disease (cGVHD).501
2026-04-09 10:01:26
- Medication Guide and Healthy Living Advice for Ibrutinib (Imbruvica)Ibrutinib is a kinase inhibitor indicated for the treatment of various B-cell malignancies and chronic graft-versus-host disease (cGVHD).501
2026-04-09 09:58:17
- Enasidenib: Indications, Contraindications, and Dosage Guidelines for Special PopulationsEnasidenib: Indications, Contraindications, and Dosage Guidelines for Special Populations501
2026-04-08 11:50:15
- Complete Analysis of Enasidenib: Mechanism of Action, Drug Interactions, and Missed Dose ManagementEnasidenib is an oral targeted therapy indicated for relapsed or refractory acute myeloid leukemia with IDH2 mutations.501
2026-04-08 09:13:55
- Enasidenib: Dosage, Precautions, and Healthy Lifestyle GuidelinesProper administration of enasidenib, avoidance of treatment risks, and adoption of a healthy lifestyle are critical to enhancing therapeutic efficacy and ensuring safety.502
2026-04-07 11:35:27
- Enasidenib: Side Effects, Management Strategies, and Storage GuidelinesWhile treating IDH2-mutant acute myeloid leukemia (AML), enasidenib may cause various adverse reactions.503
2026-04-07 11:32:20
- Dosage and Administration, Precautions, and Healthy Lifestyle for CenobamateCenobamate is a novel once-daily oral antiepileptic drug. Correct dosage and administration, strict adherence to precautions, and a healthy lifestyle are critical to ensuring its efficacy and safety.505
2026-04-03 10:22:11
- Side Effects of Cenobamate and Management StrategiesCenobamate is an effective novel antiepileptic drug, but it is associated with a range of side effects.505
2026-04-03 10:09:19
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved